You searched for fda - Page 98 of 105

Gov Perry distances himself from Celltex, clinic that gave him stem cell transplant

June 26, 2012 / Professor Paul Knoepfler, Ph.D.

The big news yesterday was that the FDA report on its audit of Celltex went public and the report was a laundry list of FDA concerns. However, another very surprising and significant element of the story went largely unnoticed. I’m talking about Governor Rick Perry’s reaction to the story. Rick Perry was asked to comment […]

Gov Perry distances himself from Celltex, clinic that gave him stem cell transplant Read More »

The interactome of the adult stem cell universe

June 23, 2012 / Professor Paul Knoepfler, Ph.D. / 2 Comments

Adult stem cell clinics are growing fast across the U.S. and the world. Many questions surround them. How do they get patients? How does the money flow? How does the FDA view them? How do all the different parties interact?In science when we study how various proteins or other molecules interact as a system we

The interactome of the adult stem cell universe Read More »

The stem cell gestalt of Geron Goodbye and the future of ACT

June 22, 2012 / Professor Paul Knoepfler, Ph.D. / 6 Comments

Last year one of the biggest events in the stem cell field was biotech Geron punting its embryonic stem cell (ESC) program. Much consternation followed. Some folks opposed to ESCs happily pronounced ESC research dead. Some folks in favor of ESC thought the world was ending a year early. Others tried to look on the

The stem cell gestalt of Geron Goodbye and the future of ACT Read More »

Lessons from Google Ads for Stem Cell Clinics in May 2012

May 21, 2012 / Professor Paul Knoepfler, Ph.D. / 2 Comments

Stem-cell-clinic-advertisement-e1467321555262

The number of stem cell clinics both in the U.S. and around the world continues to accelerate. There are in fact so many clinics that it would be difficult to keep track of them all. As a way of simply dipping one’s toe in the water of the ocean of clinics, I did a “stem

Lessons from Google Ads for Stem Cell Clinics in May 2012 Read More »

Why did I have a dialogue with ICMS?

May 17, 2012 / Professor Paul Knoepfler, Ph.D. / 3 Comments

Yesterday I did an interview with the President of ICMS and then today I did a follow-up post providing my recommendations to them publicly on how they should move forward. Why did I do this? Or to paraphrase a stem cell scientist who just now let me have it: “Why the #*@#$&^# did you do

Why did I have a dialogue with ICMS? Read More »

Recommendations to ICMS for improved practices

May 17, 2012 / Professor Paul Knoepfler, Ph.D.

Yesterday I posted an interesting interview with ICMS President Dr. Ricardo Rodriguez. I again thank Rodriguez for participating. Please note that one issue that I had already raised to Dr. Rodriguez was that I could not find the membership of their IRB listed on their website and this was apparently just addressed as that information can

Recommendations to ICMS for improved practices Read More »

ICMS President Rodriguez interview on adult stem cell regulatory issues

May 16, 2012 / Professor Paul Knoepfler, Ph.D. / 17 Comments

The International Cellular Medicine Society (ICMS) has emerged as an important organization related to stem cell regulatory issues. I think that many people do not understand what ICMS is all about and it certainly evokes strong opinions in the stem cell field. If you care about stem cells then you need to know about ICMS

ICMS President Rodriguez interview on adult stem cell regulatory issues Read More »

Billionaire Malone infuses Regenerative Sciences with millions in cash: what’s the scoop?

May 13, 2012 / Professor Paul Knoepfler, Ph.D. / 4 Comments

Regenerative Sciences, Inc. just announced in a press release (PR) that John C. Malone (pictured above in their PR), Ph.D. has “joined the Regenexx Team”. Malone has infused the restive stem cell company with millions in cash. Regenerative Sciences is the adult stem cell company run by Dr. Chris Centeno of the Centeno/Schultz Clinic that is locked in

Billionaire Malone infuses Regenerative Sciences with millions in cash: what’s the scoop? Read More »

TGIF: headlines on stem cells for May 11

May 11, 2012 / Professor Paul Knoepfler, Ph.D. / 2 Comments

Of course stem cells and their caretakers never sleep or take the weekend off, right? But still TGIF! Last week we had some really good and some ugly stem cell headlines that I covered here. How was this week? Good. ES cell differentiation requires chromatin compaction. A PLoS Genetics paper by a team led by Yuhong

TGIF: headlines on stem cells for May 11 Read More »

Taboo topics about iPS cells: the elephant in the lab series

May 10, 2012 / Professor Paul Knoepfler, Ph.D. / 7 Comments

elephant-in-the-lab-covid-19-lab-ramp-up

Wait, what’s that taboo elephant doing in the IPS cell lab? You don’t see it? I’m starting a new series called “The Elephant in the Lab” where I discuss controversial laboratory topics that people are usually too afraid to publicly discuss. We are starting with iPS cells. (for a description and definition of iPS cells

Taboo topics about iPS cells: the elephant in the lab series Read More »

Search Results for: fda